bisoprolol has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bisoprolol was associated with a lower heart rate (17 beats per minute, p=0." | 2.82 | Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study. ( Allaart, CP; Bogaard, HJ; de Boer, K; de Man, FS; Handoko, ML; Harms, HJ; Heymans, MW; Marcus, JT; Raijmakers, PG; van Campen, JS; van de Veerdonk, MC; van der Bruggen, CE; Vonk Noordegraaf, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Campen, JS | 1 |
| de Boer, K | 1 |
| van de Veerdonk, MC | 1 |
| van der Bruggen, CE | 1 |
| Allaart, CP | 1 |
| Raijmakers, PG | 1 |
| Heymans, MW | 1 |
| Marcus, JT | 1 |
| Harms, HJ | 1 |
| Handoko, ML | 1 |
| de Man, FS | 1 |
| Vonk Noordegraaf, A | 1 |
| Bogaard, HJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Beta-blocker Therapy in Idiopathic Pulmonary Arterial Hypertension[NCT01246037] | Phase 1/Phase 2 | 30 participants (Anticipated) | Interventional | 2011-02-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for bisoprolol and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study.
Topics: Adult; Aged; Antihypertensive Agents; Bisoprolol; Cross-Over Studies; Double-Blind Method; Exercise; | 2016 |